Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Yanks have had time to watch and digest the presentation before their market opens so would expect a strong afternoon here
.
All part of the plan
Times article
IMC
VOX
Consillium must have even more planned
IPad trader the 65% reduction is from a patient from cohort 3 lol
Seller using this as a liquidity event
No biggie
Company is on a one way path to a TO now
its inevitable
These patients seeing tumour reductions weren't even supposed to respond if I am correct they were just taking the drug to prove its safety
"A fortnightly dosing study to optimise the selection of the Phase 2 dose is now screening patients in the United States"
Does this mean it's been approved by the FDA?
Imagine that
Expecting a lot of after market activity also in the coming sessions
People are not feeling fearful here at all are they
It's as simple as this
Doxobrubicin is HIHGLY effective cancer destroyer
The ONLY thing stopping it killing cancer cells is its side effects
which avacta have eradicated
Patients who are responding to straight dox have to be taken of it due to side effects
Now they don't
Efficacy will be much better, how can it not be when given at stronger doses and for longer
AVA6K is doxorubicin it is identical
There is no risk. AVACTA will become a multibillon poind company. Its as simple as that
Not pocket change that.
Https://x.com/MylesMcNulty/status/1734283783078019189?s=20
link
Sounds like a margin call?
Good thread here on twitter between RAH and Myles
Shame ofraudian had to get his head in but otherwise its iluminating
Just 50 patients needed in the pivotal phase 2
Avacta will become a multibillion pound company
£20 is seriously undervaluing this as it equates to < £10bn
Big pharma will do a DCF on just AVA6K and realise even that alone is worth more than £20 a share
Then throw in 3999 and the rest of the pipeline
plus the affirmer platform and diagnostics business
We need to be thinking bigger
£20 a share right now whilst were in phase 1 maybe but as time ticks on that has to go up as the value of the IP increases and there is less and less risk for any investor
Remember we have a platform technology ready to take centre stage in a £200bn market
£20 seriously?
Can anyone tell me why cleaved doxorobucin won't act exactly the same as straight doxoburicin given they are absolutely identical in every way?
No, thought not.
AVACTA will become a multi billion pound company and a lot quicker than most realise.
your looijng at a rare opportunity to buy at the bottom of a bear market with sentiment on the floor and price also held back by CLN selling. Right now, if you can hold more than 5 minutes I say avacta shares are a licecen to print money
P1A data already outstanding in terms of safety and efficacy
Will include As much of C7 data as possible (mybe all off it) so at 3.5x the normal levels of chemo this could be extraordinarily good
On the back of the abbove FDA grant our 2weekly dosing cycle of dox in new patients as a 1st line treatment
I expect that very soon if not on wednesday as Dr Tap as worked with AVCT and the fDA all the way
Deals wont be far behind
It will be a fight between big pharma who gets in first with avacta
Conversations already started i'm sure
Couldnt be more excited about avacta
JT, thanks for reply but why don't you think heights could be responsible for the volume that has been sold of late? If they can sell down from there core holding of 40m as long as price is above 119p then surely they have 40m worth of stock to flog??
Starbright thank you for your replies
II want to understand more about what heights can and carnt do with there shares. I get every quarter they exercise and dump there loan repayment and interest so thats fine
BUT.. is it true that they have or had around 40m of stock and they can sell as much as they want above 119p
If it snot height s then who is it with this volume selling as I cartn believe it is PI's as we are seeing 100k clips, 200k clips so routinely now something just doesnt seem right. Unless... its heights in which case I coudlnt care less because its obvious why they would sell